171 related articles for article (PubMed ID: 28697999)
1. The protective role of TET2 in erythroid iron homeostasis against oxidative stress and erythropoiesis.
Guo S; Jiang X; Wang Y; Chen L; Li H; Li X; Jia Y
Cell Signal; 2017 Oct; 38():106-115. PubMed ID: 28697999
[TBL] [Abstract][Full Text] [Related]
2. TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression.
Okashita N; Kuroki S; Maeda R; Tachibana M
Sci Rep; 2019 Sep; 9(1):13462. PubMed ID: 31530896
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages.
Harada N; Kanayama M; Maruyama A; Yoshida A; Tazumi K; Hosoya T; Mimura J; Toki T; Maher JM; Yamamoto M; Itoh K
Arch Biochem Biophys; 2011 Apr; 508(1):101-9. PubMed ID: 21303654
[TBL] [Abstract][Full Text] [Related]
4. [Erythroferrone, an erythroid regulator of iron metabolism].
Kautz L
Med Sci (Paris); 2014 Oct; 30(10):834-6. PubMed ID: 25311013
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide induces a significant increase in iron content in the liver and spleen of mice.
Sheng Y; Chen YJ; Qian ZM; Zheng J; Liu Y
Hum Exp Toxicol; 2020 Jul; 39(7):973-983. PubMed ID: 32129080
[TBL] [Abstract][Full Text] [Related]
6. Heme-regulated eIF2α kinase plays a crucial role in protecting erythroid cells against Pb-induced hemolytic stress.
Wang X; Wang L; Liu S
Chem Res Toxicol; 2015 Mar; 28(3):460-9. PubMed ID: 25411909
[TBL] [Abstract][Full Text] [Related]
7. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.
Rybinska I; Cairo G
Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515
[TBL] [Abstract][Full Text] [Related]
8. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
9. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
Zhang YW; Wang Z; Xie W; Cai Y; Xia L; Easwaran H; Luo J; Yen RC; Li Y; Baylin SB
Mol Cell; 2017 Jan; 65(2):323-335. PubMed ID: 28107650
[TBL] [Abstract][Full Text] [Related]
10. Iron Mining for Erythropoiesis.
Correnti M; Gammella E; Cairo G; Recalcati S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628152
[TBL] [Abstract][Full Text] [Related]
11. Systemic iron homeostasis and erythropoiesis.
Papanikolaou G; Pantopoulos K
IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
[TBL] [Abstract][Full Text] [Related]
12. miR-214 protects erythroid cells against oxidative stress by targeting ATF4 and EZH2.
Gao M; Liu Y; Chen Y; Yin C; Chen JJ; Liu S
Free Radic Biol Med; 2016 Mar; 92():39-49. PubMed ID: 26791102
[TBL] [Abstract][Full Text] [Related]
13. TET2 plays an essential role in erythropoiesis by regulating lineage-specific genes via DNA oxidative demethylation in a zebrafish model.
Ge L; Zhang RP; Wan F; Guo DY; Wang P; Xiang LX; Shao JZ
Mol Cell Biol; 2014 Mar; 34(6):989-1002. PubMed ID: 24396069
[TBL] [Abstract][Full Text] [Related]
14. New insights into iron regulation and erythropoiesis.
Kim A; Nemeth E
Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
[TBL] [Abstract][Full Text] [Related]
15. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.
Coffey R; Jung G; Olivera JD; Karin G; Pereira RC; Nemeth E; Ganz T
Blood; 2022 Jan; 139(3):439-451. PubMed ID: 34614145
[TBL] [Abstract][Full Text] [Related]
16. Ironing out Ferroportin.
Drakesmith H; Nemeth E; Ganz T
Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
[TBL] [Abstract][Full Text] [Related]
17. Regulating ferroportin-1 and transferrin receptor-1 expression: A novel function of hydrogen sulfide.
Zhang MW; Yang G; Zhou YF; Qian C; Mu MD; Ke Y; Qian ZM
J Cell Physiol; 2019 Apr; 234(4):3158-3169. PubMed ID: 30370692
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
Wang C; Fang Z; Zhu Z; Liu J; Chen H
Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
